ICUI - ICU Medical, Inc.
224.04 -0.46 (-0.20%)
After hours: 4:18PM EDT
| Previous Close | 227.62 |
| Open | 225.64 |
| Bid | 224.18 x 900 |
| Ask | 224.40 x 1000 |
| Day's Range | 222.45 - 226.00 |
| 52 Week Range | 210.94 - 321.70 |
| Volume | 97,974 |
| Avg. Volume | 209,093 |
| Market Cap | 4.628B |
| Beta (3Y Monthly) | 0.59 |
| PE Ratio (TTM) | 88.60 |
| EPS (TTM) | 2.53 |
| Earnings Date | Aug 7, 2019 - Aug 12, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 290.00 |
- Markit•2 days ago
See what the IHS Markit Score report has to say about ICU Medical Inc.
ICU Medical Inc NASDAQ/NGS:ICUIView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for ICUI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.27 billion over the last one-month into ETFs that hold ICUI are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Thomson Reuters StreetEvents•3 days ago
Edited Transcript of ICUI earnings conference call or presentation 9-May-19 8:30pm GMT
Q1 2019 ICU Medical Inc Earnings Call
Motley Fool•14 days agoICU Medical, Inc. (ICUI) Q1 2019 Earnings Call Transcript
ICUI earnings call for the period ending March 31, 2019.
- Zacks•14 days ago
ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates
ICU Medical (ICUI) delivered earnings and revenue surprises of 18.35% and 4.13%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•14 days ago
ICU Medical: 1Q Earnings Snapshot
On a per-share basis, the San Clemente, California-based company said it had profit of $1.44. Earnings, adjusted for one-time gains and costs, were $2.58 per share. The medical device maker posted revenue ...
- GlobeNewswire•14 days ago
ICU Medical, Inc. Announces First Quarter 2019 Results
SAN CLEMENTE, Calif., May 09, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy.
- Simply Wall St.•15 days ago
Is ICU Medical, Inc. (NASDAQ:ICUI) Excessively Paying Its CEO?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Vivek Jain has been the CEO of ICU Medical, Inc. (NASDAQ:ICUI) since 2014. This analysis a...
- Zacks•21 days ago
Earnings Preview: ICU Medical (ICUI) Q1 Earnings Expected to Decline
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•28 days ago
CONMED (CNMD) Beats on Q1 Earnings, Raises '19 Guidance
Higher revenues, solid segmental performance and strong adjusted gross margins benefit CONMED's (CNMD) Q1 earnings. However, high long-term debt remains a concern.
- Zacks•28 days ago
Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates
Higher revenues, growth in APAC and strong operating margin benefit Baxter's (BAX) Q1 earnings. However, weak performance at Medication Delivery and Clinical Nutrition remains a concern.
- Zacks•29 days ago
Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised
Edwards Lifesciences (EW) gains on strong segmental contributions in Q1.
- Zacks•29 days ago
Boston Scientific (BSX) Misses Q1 Earnings, Tightens EPS View
Boston Scientific (BSX) is investing in new technologies and the global markets, which in turn, aids the uptick in sales across its most geographies in Q1.
- Zacks•29 days ago
Thermo Fisher (TMO) Beats on Q1 Earnings, Raises '19 View
Thermo Fisher (TMO) reports strong Laboratory Products and Services performance, flaunting robust global demand.
- Zacks•29 days ago
Accuray (ARAY) Q3 Earnings Top Estimates, Gross Orders Rise
Solid demand for Accuray's (ARAY) Radixact, CyberKnife and TomoTherapy platforms continue to boost business.
- Zacks•29 days ago
Merit Medical (MMSI) Q1 Earnings & Revenues Beat Estimates
Higher revenues, solid segmental performance and strong adjusted gross margins benefit Merit Medical's (MMSI) Q1 earnings. However, higher expenses remain a concern.
- Zacks•29 days ago
Stryker (SYK) Q1 Earnings Beat Estimates, Revenues In Line
Higher revenues, solid segmental performance and strong organic growth across businesses benefit Stryker's (SYK) Q1 earnings.
- Zacks•last month
Quest Diagnostics (DGX) Q1 Earnings Top Mark, Margins Down
Quest Diagnostics (DGX) currently concentrates on its core diagnostic information services business and tries to maintain discipline in capital deployment.
- Insider Monkey•last month
Were Hedge Funds Right About Souring On ICU Medical, Inc. (ICUI)?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth also depends on it. Regardless of the various methods used by elite investors like David Tepper and David […]
- GlobeNewswire•last month
ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call
SAN CLEMENTE, Calif., April 18, 2019 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion.
- Simply Wall St.•last month
Need To Know: ICU Medical, Inc. (NASDAQ:ICUI) Insiders Have Been Selling Shares
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So before you...
- Zacks•2 months ago
Baxter (BAX) Soars to 52-Week High, Time to Cash Out?
Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Reuters•2 months ago
Smiths plans to list medical unit, focus on industrial technology
The healthcare business has suffered from product delays, stricter European regulations and two lost contracts in the United States. A plan to merge it with U.S.-based ICU Medical fell through in September because Smiths and ICU could not agree on terms. "Pursuing a demerger of Smiths Medical will lead to two stronger companies, each...maximising the opportunities in their respective markets," Chief Executive Andy Reynolds Smith said.
